CN109692072A - A kind of epichoroidal space pressurization hydrogel sphere bag apparatus for rhegmatogenous detachment of retina - Google Patents

A kind of epichoroidal space pressurization hydrogel sphere bag apparatus for rhegmatogenous detachment of retina Download PDF

Info

Publication number
CN109692072A
CN109692072A CN201910018023.8A CN201910018023A CN109692072A CN 109692072 A CN109692072 A CN 109692072A CN 201910018023 A CN201910018023 A CN 201910018023A CN 109692072 A CN109692072 A CN 109692072A
Authority
CN
China
Prior art keywords
sacculus
hydrogel
injection needle
epichoroidal space
retina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910018023.8A
Other languages
Chinese (zh)
Other versions
CN109692072B (en
Inventor
李芸
赵元
曹健
陈百华
谭周辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Xiangya Hospital of Central South University
Original Assignee
Second Xiangya Hospital of Central South University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Xiangya Hospital of Central South University filed Critical Second Xiangya Hospital of Central South University
Priority to CN201910018023.8A priority Critical patent/CN109692072B/en
Publication of CN109692072A publication Critical patent/CN109692072A/en
Application granted granted Critical
Publication of CN109692072B publication Critical patent/CN109692072B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00727Apparatus for retinal reattachment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00736Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments

Abstract

The invention discloses a kind of epichoroidal space pressurization hydrogel sphere bag apparatus for rhegmatogenous detachment of retina, by hydrogel sacculus, injection needle and filler composition, hydrogel sacculus is by balloon body, head side cecum sheath and tail end self-closing valve are constituted, shape is the oblate capsule of unilateral blind pipe sample when not full, the cecum sheath tube wall of sacculus head side is than balloon body wall thickness, form the set sheath at tight injection needle tip, there is unidirectional self-closing diaphragm in balloon body, sacculus major diameter is divided into multiple compartments, sacculus caudal is connected with the dual self-closing valve of hydrogel, its internal diameter of the pipeline can be put into epichoroidal space puncture needle core, after injection needle exits, lumen is because of the elastical retraction of tube wall itself and the double action tight closing of corresponding external elastic beam ring, so that sacculus content will not leak out;There is scale on injection needle.The length, width and height of sacculus pressurization ridge of the present invention are stably and controllable adjustable, and the soak time of balloon wall determines the retention time of ridge, and inter-individual difference is small, and the success rate of operation can be improved.

Description

A kind of epichoroidal space pressurization hydrogel sphere capsule for rhegmatogenous detachment of retina Device
Technical field
The present invention relates to a kind of surgical instruments that ophthalmology retinal disease in clinical medicine uses, and are especially used for hole source property The epichoroidal space pressurization hydrogel sphere bag apparatus of detachment of retina.
Background technique
Rhegmatogenous detachment of retina is a kind of most common blinding retinal disease, which is due to retina neural There is ceasma in epithelium, and liquid enters the separation under retina and leading to neuroepithelium of retina and pigment epithelium in vitreum.Suffer from Person male is about 3: 2 more than women, and majority is 30 years old or more adult, and difference between right and left eyes, eyes disease incidence is about patient The 15% of sum.It is apt to occur in myopia, especially high myopia.
The basic principle for treating rhegmatogenous detachment of retina is close the break, promotes absorption and the retina of subretinal fluid Calm down, can be generally divided into sclera external pressure and operation on vitreous.
Segmental scleral buckling is the most classical and common art formula of rhegmatogenous detachment of retina, basic operation are as follows: overturning eye The corresponding eyeball surface of ball exposure retinal hole, the external pressurized object of silica gel or silicon sponge material is sutured through sqclerotal layer, makes office Portion's wall of eyeball invagination, choroid are bonded with retina, and form adhesion around ceasma using freezing or laser reactive to reach To the purpose of close the break.Since wall of eyeball keeps complete, eye inner tissue is disturbed it is small, few intercurrent disease and some patientss still For one of preferred embodiment.But the operation overturns eyeball due to that need to pull muscle, and feeling of pain is obvious in art, is likely to occur eyeball compression reflex Cause heartbeat slow down even all standing;Myotasis damage or postoperative cicatricial adhesion can influence eye movement and lead to diplopia in art; It is postoperative due to can lead to astigmatism, metamorphopsia to cornea and retinal morphology influence, influence chorioretinal blood fortune and outer Object infection of pressurizeing is discharged, and needs complication and the adverse reaction such as operation wound clearing taking-up again.
Operation on vitreous be after the proliferation drawing for removing vitreum and retina within filler press promote ceasma The method for being closed reattachment of retina, currently used intraocular long-acting filler have expanding gas, silicone oil, are that specific gravity is lighter than water Substance, it is bad for the press healing ability of lower section retinal hole, become the difficult point of such operation.
Emerging epichoroidal space pressurization art formula is the epichoroidal space around ceasma by the positioning to retinal hole The pressurization ridge that the long-acting viscoelastic agent such as cross-linked-hyaluronic acid (Hai Lefu) forms protuberance is injected, retina is caused at retinal hole Choroidal abutting, closing, American-European clinical application have proven to this method can provide enough pressure on top surface and success rate and Smaller to ocular nerve, myotasis, wound is small, and after-operation response is smaller, smaller to intraocular disturbance;And hyaluronic acid human body Affinity is strong, and rejection is smaller, and variety classes filler can be by dividing 1 week-June according to different crosslinking methods within the eye Solution.The method can avoid above-mentioned all complication caused by sclera external pressure object, and postoperative edema pain is considerably less than conventional method; Epichoroidal space pressurization joint operation on vitreous can then carry out satisfied supplement press to lower section ceasma, improve its success rate.
But pressurization ridge will be formed after current epichoroidal space hydrogel injection in a manner of free disperse, shape and Height be difficult to control, the selling at exorbitant prices of medical cross-linked hyaluronic acid and can injected slurry volume it is limited, be formed by pressurization ridge filler The problems such as absorption rate individual difference is big.It requires further improvement to improve controllability and success rate of operation.
Fig. 1 is figure compared with epichoroidal space pressurization art presses Surgical Operation with traditional sclera external, separates sclera with blunt nosed needle Potential lacuna -- epichoroidal space between choroid injects long-acting hyaluronic acid sodium gel and causes arteries and veins after reaching ceasma position The protuberance of network film forms pressurization ridge, wherein (a) are as follows: silicon sponge is sutured in eyeball surface figure by traditional sclera external pressure, (b) are as follows: Epichoroidal space pressurizes sacculus between sclera and choroid layer, (c) are as follows: clinical application epichoroidal space Pressurized pinhead.This The controllability of separation process and final form is poor, and once pressurization ridge position deviates, and will be unable to effectively adjust.It is long-acting Sodium Hyaluronate is expensive at present, and soak time is partially short, and soak time difference is big between individual, therefore epichoroidal space pressurizes Art requires further improvement, to improve its controllability and stability.
Summary of the invention
The object of the present invention is to provide a kind of epichoroidal space pressurization hydrogel sphere capsules for rhegmatogenous detachment of retina Device, sacculus are in normal eyes in eyeball using good biocompatibility, absorbable and adjustable absorption rate hydrogel material It is implanted into epichoroidal space in the case where position, and inject filler to make balloon inflation, is pressed using the volume mechanical after balloon dilation Retinal hole, so that scar packet outside the eyeball caused by the excessive drawing of eyeball muscle, pressurization object be reduced or avoided in operation It wraps up in and deviates from caused by infecting or rejecting, to the amount of eyeball extruding, good control padding and the height for the ridge that pressurizes, reach micro- Wound, the safe and effective effect for pressing ceasma, calming down retina.
A kind of epichoroidal space pressurization hydrogel sphere bag apparatus for rhegmatogenous detachment of retina of the present invention, by hydrogel Sacculus, injection needle and filler composition.
Hydrogel balloon structure: it is made of balloon body, head side cecum sheath and tail end self-closing valve.It is conventional when not full Monnolithic case is the unilateral oblate capsule of blind pipe sample, caliber 0.8-1.0mm, when completely full, long 10-60mm, wide 8-12mm high 4- 8mm, wall thickness are 100-1000 microns.
The form of above-mentioned numerical value and the object that pressurizes in practical applications can by it is full completely whether adjust, can also basis Individuation customization, 3D printing is embodied.When carrying out pad pressure to posterior scleral staphyloma, it is made into the circle of fitting eyeball staphyloma radian Plate-like water pocket;When carrying out cerclage, it is made into 360 DEG C of shape rings.
The cecum sheath tube wall of hydrogel sacculus head side compared with balloon body wall thickness, cecum sheath tube wall with a thickness of 0.3-0.5mm, The set sheath spline structure at tight injection needle tip is formed, it is olivary casing that a head end is formed when wrapping up injection needle The smooth passivity tissue separated structure of needle-like can effectively protect cyst wall and epichoroidal space week during epichoroidal space separation Tissue is enclosed, it is safely controllable;After after injection fillers object, sheath head with balloon expandable, loosen the package of syringe needle by expansion naturally, will not hinder Injection needle after the completion of injection is hindered to exit.
There is unidirectional self-closing diaphragm in balloon body, is divided into multiple compartments for sacculus major diameter is equidistant, is injected with injection needle Filler is full of one of them or several compartments, keeps sacculus pressurization length segmentation adjustable.
Hydrogel sacculus caudal is connected with tail end self-closing valve, and the internal diameter of the pipeline maximum tension diameter 0.6mm of tail end self-closing valve can It is put into epichoroidal space puncture needle core (25G caliber), external elastic beam ring covers outside tail end self-closing valve.It is exited in injection needle Afterwards, the lumen of balloon body is because of the elastical retraction of tube wall itself and the double action tight closing of corresponding external elastic beam ring, So that the content of balloon body will not leak out.
Sacculus material: for good, soft, lubrication the absorbable hydrogel material (PVA etc.) of biocompatibility, soak time Can by the molecule of the material of balloon wall constitute and thickness adjust, make its within the eye retention time at 2 months to the several years.Above-mentioned water Gel ball capsule material matter includes: water-soluble macromolecule (native starch, natural plant gum, animal glue (casein), chitin and sea Soluble derivative, carboxymethyl starch, acetic starch, hydroxymethyl cellulose, carboxymethyl cellulose, the polyvinylpyrrolidine of alginic acid Ketone, polyvinyl alcohol, 2- acrylamide-2-methyl propane sulfonic, 2-hydroxyethyl methacry-late, acrylic acid, methacrylic acid, first Base acrylate, 4- acryloyl morpholine, acrylamide, vinylpyrrolidone, polyethylene acrylate, acrylic acid 3- sulfonic acid propyl ester Sylvite, polyvinyl alcohol, N,N-DMAA, (3- acrylamide propyl) trimethyl ammonium chloride, 2- acrylyl oxy-ethyl Trimethyl ammonium chloride one or any of several, or be made of the monomer or cross-linking products of above-mentioned material.
Syringe needle overall length 37mm is penetrated, shape is the arc of identical wall of eyeball radian, and tip is smooth indenting ball, is had on shank Scale does not need the olive forming head of front end, only needs to determine position of the syringe needle when filler injects in different compartments outside eye The smooth indenting ball in tip is formed,.
The intracapsular filler of hydrogel sphere is any one in air, physiological saline/BSS or common sodium hyaluronate Kind, it can according to need selection, the controllability and retention time of Sodium Hyaluronate are best.
In use, filler injection plain head is first passed through tail end self-closing valve and balloon body inner septum, it is inserted into head end set Then intrathecal tight carries out the separation of epichoroidal space by scleral incision, inject content when reaching the position of quasi- pressurization Object fills the length of hydrogel sacculus to needs, and adjusts hydrogel balloon position to backed off after random injection needle is satisfied with, and makes Hydrogel sacculus is retained in epichoroidal space, absorbs after a set time.
The present invention is by a kind of temporary epichoroidal space pressurizing device come more controllable more minimally invasive formation epichoroidal space Pressurization ridge, the set sheath spline structure at injection needle tip can effective protection cyst wall and train of thought during epichoroidal space separates Epistege surrounding tissue, it is safely controllable;Balloon body has unidirectional self-closing diaphragm to keep sacculus pressurization length segmentation adjustable, and lumen is because of pipe The double action tight closing of the elastical retraction of wall itself and corresponding external elastic beam ring, so that the content of hydrogel sacculus It will not leak out, avoid or reduce the relevant complication of external pressurized object and risk, increase success rate of operation, reduce patients surgery pain Bitter, shortening operating time, reduces operation cost/expense, improves such disease prognosis.The difference of hydrogel sphere capsule volume and size Parameter determines that the length, width and height of pressurization ridge are stably and controllable, and the soak time of balloon wall determines the retention time of ridge, poor between individual It is different small.
Detailed description of the invention
Fig. 1 is figure compared with epichoroidal space pressurization art presses Surgical Operation with traditional sclera external;A is sclera external pressure, often It is sewn to eyeball surface with silica gel, silicon sponge, makes eyeball deformation invagination, the operation of suture and the external pressurized object of eyeball surface itself A series of complication can be brought;B is epichoroidal space pressurization, and pressurization level is in eyeball inner face, without overturning eyeball suture, Avoid traditional sclera external pressure some serious problems of bring;C is the olive shape head end of epichoroidal space Pressurized pinhead upper When chamber separation and operation safely, effectively.
Fig. 2 is structure chart when epichoroidal space of the present invention pressurization sacculus is full;Wherein a be front view, b side view, c cut Face figure;
Fig. 3 is structure chart when epichoroidal space of the present invention pressurization sacculus is not full;
Fig. 4 epichoroidal space pressurization sacculus application method schematic diagram.Its a is sectional view, and b is injection connection signal face figure.
Specific embodiment
The detailed description of a step is done to the present invention with reference to the accompanying drawing.The given examples are served only to explain the present invention, not uses In limiting the scope of the invention.
Embodiment 1
As shown in Figure 2 and Figure 4, the present invention is made of hydrogel sacculus 1, injection needle 8 and filler 2, hydrogel sacculus 1 It is made of balloon body, head side cecum sheath 3, tail end self-closing valve 5 and external elastic beam ring 6, when not full, monnolithic case is single The oblate capsule of side blind pipe sample, the tube wall of head side cecum sheath 3 form the tip sleeve of tight injection needle 8 than balloon body wall thickness Sheath spline structure, effective protection cyst wall and epichoroidal space surrounding tissue during epichoroidal space separation;It is filled in injection After object 2, the sheath head of head side cecum sheath 3 is expanded with hydrogel sacculus 1, and the package loosened to injection needle 8 is unfolded naturally;Sacculus master There is unidirectional self-closing diaphragm 4 in vivo, is divided into multiple compartments for balloon body major diameter is equidistant, filler 2 is connected to note by hose 7 Syringe needle 8 is penetrated, filler 2 is full of by one of them or several compartments by injection needle 8, makes the pressurization length point of hydrogel sacculus 1 Section is adjustable;The caudal of hydrogel sacculus 1 is connected with tail end self-closing valve 5, and the internal diameter of the pipeline of tail end self-closing valve 5 can be put into epichoroidal space Puncture needle core, 6 sets of external elastic beam ring is in 5 outside of tail end self-closing valve, after injection needle 8 exits, the lumen of hydrogel sacculus 1 because The elastical retraction of tube wall itself and the double action tight closing of external elastic beam ring 6, so that the filler 2 of hydrogel sacculus 1 It will not leak out;8 overall length 37mm of injection needle, shape are the arc of identical wall of eyeball radian, and tip is smooth indenting ball, shank On have scale, so as to outside eye determine syringe needle different compartments 4 inject filler 2 position, the filler 2 of hydrogel sacculus 1 For air, physiological saline, BSS or sodium hyaluronate.Fig. 3 is structure chart when epichoroidal space pressurization sacculus is not full.
There is unidirectional self-closing diaphragm 4 in balloon body, is divided into multiple compartments for balloon body major diameter is equidistant, uses injection needle Injection fillers object is full of one of them or several compartments, keeps the pressurization of hydrogel sacculus 1 length segmentation adjustable.Use behaviour of the invention Make step:
(1) conjunctiva of retinal hole quadrant is cut in art, exposure sclera utilizes indirect ophthalmoscope or surgical operation microscope It determines ceasma position and marks.
(2) make the 1-1.5mm meridian apart from corneal limbus 4mm to holostrome scleral incision to expose choroid.
(3) one 1-2 millimeters of pocket, and the preset suture of indwelling are created, for introducing conduit on choroid.
(4) by hydrogel sphere cuff on epichoroidal space puncture needle, hydrogel sacculus itself can play Olivary head at this time Injection needle 8 with casing is placed in epichoroidal space by pocket by effect, and process of passing through tunnel is put into target position.
(5) after reaching target position, shank high scale is observed when moving back, after reaching balloon body target position, through injecting Syringe needle 8 is squeezed into balloon body tamps object 2, observes pressurization ridge height after making a compartment and whether width is suitable, if not It is suitable then adjust syringe needle to second compartment, filler is played in compartment, unidirectionally self-closing diaphragm is self-closing for first compartment at this time.
(6) indwelling of hydrogel sacculus determines ceasma closed state in epichoroidal space, such as not repeatable enough 4-5 step, position Setting undesirable can adjust hydrogel balloon position to satisfaction in epichoroidal space.

Claims (6)

  1. The hydrogel sphere bag apparatus 1. a kind of epichoroidal space for rhegmatogenous detachment of retina pressurizes, it is characterised in that: by water Gel sacculus, injection needle and filler composition, hydrogel sacculus is by balloon body, head side cecum sheath, tail end self-closing valve and outer It encloses elastic beam ring to constitute, the cecum sheath tube wall of sacculus head side forms tight injection needle tip than balloon body wall thickness Sheath spline structure is covered, it is the smooth passivity tissue separated structure of olivary casing needle-like that a head end is formed when wrapping up injection needle, Effective protection cyst wall and epichoroidal space adjacent tissue during epichoroidal space separation;After injection fillers object, head side The sheath head of cecum sheath with hydrogel balloon expandable, loosen the package of injection needle by expansion naturally;Have in balloon body unidirectional self-closing Diaphragm is divided into multiple compartments for balloon body major diameter is equidistant, with injection needle injection fillers object full of one of them or it is several Compartment keeps hydrogel sacculus pressurization length segmentation adjustable;Hydrogel sacculus caudal is connected with tail end self-closing valve, the self-closing valve pipeline of tail end Internal diameter can be put into epichoroidal space puncture needle core, and external elastic beam ring covers outside tail end self-closing valve, after injection needle exits, ball The lumen of capsule main body is in the elastical retraction of tube wall itself and the double action tight closing of external elastic beam ring, and sacculus content is not It can leak out;Injection needle shape is the arc of identical wall of eyeball radian, and tip is smooth indenting ball, has scale on shank, really Determine position of the injection needle when filler injects in different compartments, the filler of hydrogel sacculus is air, physiological saline, BSS Or sodium hyaluronate.
  2. 2. a kind of epichoroidal space pressurization hydrogel sphere capsule dress for rhegmatogenous detachment of retina as described in claim 1 It sets, it is characterised in that: hydrogel sphere capsule material matter is good, soft, lubrication the absorbable hydrogel material of biocompatibility, sacculus The molecule of main body wall material is constituted and thickness is adjustable.
  3. 3. a kind of epichoroidal space pressurization hydrogel sphere capsule dress for rhegmatogenous detachment of retina as described in claim 1 It sets, it is characterised in that: hydrogel sacculus caliber is 0.8-1.0mm, when completely full, long 10-60mm, wide 8-12mm, high 4- 8mm, balloon body wall thickness are 100-1000 microns.
  4. 4. a kind of epichoroidal space pressurization hydrogel sphere capsule dress for rhegmatogenous detachment of retina as described in claim 1 It sets, it is characterised in that: cecum sheath pipe thickness is 0.3-0.5mm.
  5. 5. a kind of epichoroidal space pressurization hydrogel sphere capsule dress for rhegmatogenous detachment of retina as described in claim 1 It sets, it is characterised in that: tail end self-closing valve internal diameter of the pipeline maximum tension diameter is 0.6mm.
  6. 6. a kind of epichoroidal space pressurization hydrogel sphere capsule dress for rhegmatogenous detachment of retina as described in claim 1 It sets, it is characterised in that: hydrogel sacculus is by when not full, monnolithic case is the oblate capsule of unilateral blind pipe sample, or to posterior scleral When staphyloma carries out pad pressure, hydrogel sacculus is made into the discoid water pocket of fitting eyeball staphyloma radian;Or when carrying out cerclage, Hydrogel sacculus is made into 360 DEG C of shape rings.
CN201910018023.8A 2019-01-09 2019-01-09 Suprachoroidal space pressurized hydrogel balloon device for rhegmatogenous retinal detachment Expired - Fee Related CN109692072B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910018023.8A CN109692072B (en) 2019-01-09 2019-01-09 Suprachoroidal space pressurized hydrogel balloon device for rhegmatogenous retinal detachment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910018023.8A CN109692072B (en) 2019-01-09 2019-01-09 Suprachoroidal space pressurized hydrogel balloon device for rhegmatogenous retinal detachment

Publications (2)

Publication Number Publication Date
CN109692072A true CN109692072A (en) 2019-04-30
CN109692072B CN109692072B (en) 2021-07-09

Family

ID=66232579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910018023.8A Expired - Fee Related CN109692072B (en) 2019-01-09 2019-01-09 Suprachoroidal space pressurized hydrogel balloon device for rhegmatogenous retinal detachment

Country Status (1)

Country Link
CN (1) CN109692072B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110302005A (en) * 2019-07-16 2019-10-08 上海交通大学医学院附属第九人民医院 A kind of posterior scleral quantifies pressurizing block and its application method
CN110859702A (en) * 2019-11-21 2020-03-06 广州卫视博生物科技有限公司 Folding top pressing balloon structure
CN111808800A (en) * 2020-07-20 2020-10-23 中南大学湘雅二医院 In-vitro induced immunosuppressive myeloid suppressor cell and preparation and application thereof
WO2022127763A1 (en) * 2020-12-14 2022-06-23 中国人民解放军总医院 Nailing type retinal hole sealer and implant

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299227A (en) * 1979-10-19 1981-11-10 Lincoff Harvey A Ophthalmological appliance
DE3608666A1 (en) * 1986-03-14 1987-09-17 Stanowsky Alexander Dr Med Episcleral filling for the treatment of retinal detachment
US4818121A (en) * 1987-07-23 1989-04-04 Volk Henry J Carrying handle
US5286261A (en) * 1990-08-30 1994-02-15 Jaime Roizenblatt Inflatable balloon for treatment of rental detachments
CN201019909Y (en) * 2007-01-31 2008-02-13 耿燕 Medical sacculus eye outer top pressing device
CN101625042A (en) * 2008-07-07 2010-01-13 烨昆实业有限公司 Airbag backstop device structure
US20130046325A1 (en) * 2011-08-19 2013-02-21 Gholam A. Peyman Scleral buckling procedure and device
CN203107411U (en) * 2013-03-15 2013-08-07 徐国兴 Eye pressurization ball bag
US20130245600A1 (en) * 2006-02-22 2013-09-19 Iscience Interventional Corporation Apparatus and formulations for suprachoridal drug delivery
US20140074128A1 (en) * 2012-09-07 2014-03-13 Robert Park Eye Shape Modification Systems
CN204972652U (en) * 2015-07-14 2016-01-20 赵家鹏 Oppression gasbag
CN106029019A (en) * 2014-02-26 2016-10-12 阿勒根公司 Intraocular implant delivery apparatus and methods of use thereof
WO2018013819A1 (en) * 2016-07-13 2018-01-18 Massachusetts Eye And Ear Infirmary Methods and polymer compositions for treating retinal detachment and other ocular disorders
CN107928869A (en) * 2017-12-07 2018-04-20 胡园园 A kind of artificial pouch
CN207323774U (en) * 2017-01-25 2018-05-08 中国人民解放军总医院第一附属医院 A kind of drainage system
CN108272483A (en) * 2018-01-26 2018-07-13 东南大学 A kind of segmented airbag hemostasis device

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299227A (en) * 1979-10-19 1981-11-10 Lincoff Harvey A Ophthalmological appliance
DE3608666A1 (en) * 1986-03-14 1987-09-17 Stanowsky Alexander Dr Med Episcleral filling for the treatment of retinal detachment
US4818121A (en) * 1987-07-23 1989-04-04 Volk Henry J Carrying handle
US5286261A (en) * 1990-08-30 1994-02-15 Jaime Roizenblatt Inflatable balloon for treatment of rental detachments
US20130245600A1 (en) * 2006-02-22 2013-09-19 Iscience Interventional Corporation Apparatus and formulations for suprachoridal drug delivery
CN201019909Y (en) * 2007-01-31 2008-02-13 耿燕 Medical sacculus eye outer top pressing device
CN101625042A (en) * 2008-07-07 2010-01-13 烨昆实业有限公司 Airbag backstop device structure
US20130046325A1 (en) * 2011-08-19 2013-02-21 Gholam A. Peyman Scleral buckling procedure and device
US20140074128A1 (en) * 2012-09-07 2014-03-13 Robert Park Eye Shape Modification Systems
CN203107411U (en) * 2013-03-15 2013-08-07 徐国兴 Eye pressurization ball bag
CN106029019A (en) * 2014-02-26 2016-10-12 阿勒根公司 Intraocular implant delivery apparatus and methods of use thereof
CN204972652U (en) * 2015-07-14 2016-01-20 赵家鹏 Oppression gasbag
WO2018013819A1 (en) * 2016-07-13 2018-01-18 Massachusetts Eye And Ear Infirmary Methods and polymer compositions for treating retinal detachment and other ocular disorders
CN207323774U (en) * 2017-01-25 2018-05-08 中国人民解放军总医院第一附属医院 A kind of drainage system
CN107928869A (en) * 2017-12-07 2018-04-20 胡园园 A kind of artificial pouch
CN108272483A (en) * 2018-01-26 2018-07-13 东南大学 A kind of segmented airbag hemostasis device

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
INGRID KREISSIG: "primary retinal detachment: A review of the development of techniques for repari in the past 80 years", 《TAIWAN JOURNAL OF OPHTHALMOLOGY》 *
SUHANA A, NATARAJ A, EL-RAYES EN: "Suprachoroidal buckling: A novel technique for rhegmatogenous retinal detachment and vitreoretinal interface pathologies", 《KERALA J OPHTHALMOL》 *
杨薇: "视网膜脱离显微外路手术与传统外路手术的临床比较", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *
耿燕,张振华,杨朝忠,顾艳枝: "眼用双腔球囊顶压器在孔源性视网膜脱离复位术中的应用", 《眼科新进展》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110302005A (en) * 2019-07-16 2019-10-08 上海交通大学医学院附属第九人民医院 A kind of posterior scleral quantifies pressurizing block and its application method
CN110859702A (en) * 2019-11-21 2020-03-06 广州卫视博生物科技有限公司 Folding top pressing balloon structure
WO2021098155A1 (en) * 2019-11-21 2021-05-27 广州卫视博生物科技有限公司 Folding pressing-type balloon structure
CN110859702B (en) * 2019-11-21 2022-03-01 广州卫视博生物科技有限公司 Folding top pressing balloon structure
CN111808800A (en) * 2020-07-20 2020-10-23 中南大学湘雅二医院 In-vitro induced immunosuppressive myeloid suppressor cell and preparation and application thereof
WO2022127763A1 (en) * 2020-12-14 2022-06-23 中国人民解放军总医院 Nailing type retinal hole sealer and implant

Also Published As

Publication number Publication date
CN109692072B (en) 2021-07-09

Similar Documents

Publication Publication Date Title
CN109692072A (en) A kind of epichoroidal space pressurization hydrogel sphere bag apparatus for rhegmatogenous detachment of retina
US9308082B2 (en) Ocular collar stent for treating narrowing of the irideocorneal angle
US20080027304A1 (en) Intraocular pressure attenuation device
CN105726166B (en) Shape-memory polymer intraocular lens
Baino Scleral buckling biomaterials and implants for retinal detachment surgery
JP2013516215A (en) Ophthalmic surgical apparatus and method for performing ophthalmic surgery
US10265161B2 (en) Ocular collar stent for treating narrowing of the irideocorneal angle
CN101049270B (en) Bracket of vitreous body cavity for curing retina disease, and manufacturing method
US9974645B2 (en) Method of reducing the occurrence of macular and neuroretinal degenerations by alleviating age related retinal stresses as a contributing factor in a mammalian eye
Xu et al. Outcomes of a foldable capsular vitreous body implantation: a retrospective study
RU2559177C1 (en) Method for rsp-3 flexible pupillary intraocular lens implantation following microcoaxial phacoemulsification
RU2662426C1 (en) Method of mini-invasive reposition of the intraocular lens dislocated into the vitreal cavity
RU2809441C1 (en) Method of implantation and suture fixation of soft intraocular lens to iris in absence of capsular support
RU2561002C1 (en) Method for phacoemulsification in floppy iris syndrome
RU2760172C1 (en) Method for implantation of a three-part intraocular lens in the presence of lens subluxation
RU2779992C1 (en) Method for eliminating iridodialysis
RU2272600C1 (en) Method for treating patients for cornea and lens diseases
RU2217113C2 (en) Method for fixing intraocular lens in performing repeated implantation
RU2154448C2 (en) Surgical method for treating cataract combined with vitreous body destruction
RU2195240C1 (en) Method for treating aphakia in children
RU2102952C1 (en) Pupil dilation method useable in ophthalmic surgical operations
RU134783U1 (en) Intracapsular iris simulator
Liu et al. Clinical Efficacy and Safety of Foldable Capsular Vitreous Body Implant Surgery in 22 Cases of Silicone Oil-dependent Eyes
RU2201182C2 (en) Method for removing eye lens or vitreous body through the flat part of the ciliary body
RU2138231C1 (en) Surgical method for treating cataract and amotio retinae in single operation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210709

Termination date: 20220109

CF01 Termination of patent right due to non-payment of annual fee